5440292025-04-012025-06-305440292025-04-012025-06-30in-capmkt:OtherExpenses1Member5440292025-04-012025-06-30in-capmkt:OtherExpenses2Member5440292025-04-012025-06-30in-capmkt:OtherExpenses3Member5440292025-04-012025-06-30in-capmkt:OtherExpenses4Member5440292025-04-012025-06-30in-capmkt:OtherExpenses5Member5440292025-04-012025-06-30in-capmkt:OtherExpenses6Member5440292025-04-012025-06-30in-capmkt:OtherExpenses7Member5440292025-04-012025-06-30in-capmkt:OtherExpenses8Member5440292025-04-012025-06-30in-capmkt:OtherExpenses9Member5440292025-04-012025-06-30in-capmkt:OtherExpenses10Member5440292025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15440292025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544029GANDHARLISTEDINE717W01049GANDHAR OIL REFINERY (INDIA) LIMITEDMain BoardEquity2025-04-012026-03-312025-08-08INRMillionsQuarterlyFirst quarterSingle segmentpetroleum products specialty oils2025-08-0811:30:002025-08-0812:45:00Not applicable2025-04-012025-06-30UnauditedConsolidated902961000026930000905654000080877800000-7046000011511000096120000726100004376000008738760000317780000031778000057130000-2500005688000002609000000000260900000-5810000255090000262290000-1390000258590000-350000019576000022.682.68002.682.680.00140.04790.04031 The Statement of Consolidated Unaudited Financial Results for the quarter ended June 30 2025 have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 Interim Financial Reporting Ind AS 34 prescribed under Section 133 of the Companies Act 2013 and other accounting principles generally accepted in India read with relevant rules issued thereunder and in terms of the Securities and Exchange Board of India Listing Obligations and Dislcosure Requirements Regulations 2015 as amended Listing Regulations. <BR> 2 The above Unaudited consolidated financial results have been reviewed and recommended by Audit Committee and approved by the Board of Directors at their respective meetings held on August 08 2025. <BR> 3 The Parent Company has received an amount of Rs 3020.00 million Net Proceeds Rs.2785.38 million Rs.3174.35 Million including IPO Expenses from proceeds out of fresh issue of equity shares. The utilisation of IPO proceeds is summarised as under <BR> <BR> Objects of the Issue Amount to be <BR> utilised as per Prospectus Utilisation up to June 30 <BR> 2025 Unutilised amount <BR> as on June 30 2025 <BR> Investment into subsidiary company Texol Lubritech FZC by way of a loan for financing the repayment prepayment of a loan facility availed by Texol Lubritech FZC from the Bank of Baroda 227.13 227.13 <BR> Capital expenditure through purchase of equipment and civil work required for expansion in capacity of <BR> automotive oil at our Silvassa Plant 277.29 277.12 0.17 <BR> Funding working capital requirements of our Company 1850.08 1911.29 61.21 <BR> General corporate purposes & IPO Expenses 819.85 758.22 61.63 <BR> Net Proceeds 3174.35 3173.76 0.59 <BR> 4 The Group is primarily engaged in manufacturing and trading of of petroleum products specialty oils. Accordingly the company has only one reportable segment petroleum products specialty oils as per IND AS 108 Operating Segment. <BR> 5 The consolidated amounts for the quarter ended 31st March 2025 are the balancing amounts between the audited amounts in respect of the full financial year and the limited reviewed year to date amounts upto the third quarter of the relevant financial year. <BR> 6 Previous quarters years figures have been regrouped rearranged wherever necessary to confirm to those of current quarter year classification. <BR> <BR> 7 The above results are available on the Companys website www.gandharoil.com and also on the website of BSE www.bseindia.com and NSE www.nseindia.com where the shares of the Company are listed.Consumption of Stores and Spares8480000Power and Fuel13720000Electricity Charges1190000Labour Charges25000000Water Charges110000Security Charges2230000Repairs and Maintenance31670000Laboratory Expenses20000Rsesearch & Development expenditure10290000Others344890000Remeasurement of Defined benefit -Actuarial Gain/Loss-2110000-2110000-530000Exchange differences in translating financial statement of foreign operations-4230000-42300000-5810000